Skip Navigation
Skip to contents
Results by Year

View Wide

Filter

ARTICLE TYPE

more+
SELECT FILTER
 
Close

PUBLICATION DATE

358 results
Display

Should We Intensify Statin Management in ACS Patients with Very Low LDL Cholesterol Levels?

Han KH

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Lipid Profiles in Hypertension and Cerebrovascular Diseases

Han IK, Park CK, Kim MS, Kim MH, Bai JH, Song JS

Serum lipids and lipoproteins were determined in 70 patients with hypertension, 40 patients with cerebral infarctions, and 41 patients with cerebral hemorrhage. The results were compared with findings in 64...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Low Density Lipoprotein Cholesterol Target Goal Attainment Rate in Korean Patients with Diabetes

Lee EH, Ahn CW

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A Study on the Serum Lipid Level In Hypertensive Patients

Chung SJ, Kim KS

The plasma cholesterol, TG,LDG,HDL of 101 Korean hypertensive patients were measured to compare with plasma cholesterol, TG,LDL,HDL level of healthy people(control group). The plasma cholesterol level in hypertensive patients was 189.6+/-39.5mg%...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Serum Lipoprotein Composition in Diabetes Mellitus

Hong YS, Sung NE, Kyung NH, Lee SN

Lipoprotein cholesterol and triglyceride levels have been determined innormal and diabetes. The abnormalities of lipoprotein were investigated by SDS-polyacrylamide gel electrophoresis in the serum and the 3 major lipoprotein classes...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Cholesterol Lowering Therapy in Coronary Artery Disease: With Particular Reference to Statins

Jun JE

Statins (HMG-CoA reductase inhibitors) are widely used lipid lowering agents. They effectively reduce LDL cholesterol (LDL-C), lower triglyceride levels and are very safe. Recent large-scale clinical trials have demonstrated that...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Dyslipidemia Treatment in Diabetes Mellitus Patients

Kim SR

Cardiovascular disease (CVD) is the major cause of mortality and morbidity in patients with type 2 diabetes mellitus. The increased risk of CVD in subjects with type 2 diabetes mellitus...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Effects of Lovastatin(Mevacor(R)) on Lowering Plasma Lipids in Patients with Hyperlipidemia

Lee HJ, Min CH, Choi KS, Ryu WS, Ryoo UH

Lovastatin, a competitive inhibitor of the rate limiting enzyme in cholesterol biosynthesis was administered to 34 patients with primary hypertlipidemia, 20 mg once daily with the evening meal. Patients experienced...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
High Density Lipoprotein Cholesterol Comes of Age

Cho H

Despite the excellent success of lowering low-density lipoprotein cholesterol (LDLc) cholesterol for treating coronary heart disease (CHD), a major part of the population still suffer from CHD. This fact is...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Epidemiology of dyslipidemia in Korea

Kim HC

Cardiovascular disease is the leading cause of death worldwide and the second most common cause of death in Korea. Dyslipidemia is among the major modifiable risk factors for cardiovascular disease....
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Effect of Pravastatin on Serum Lipids of Patient with Primary Hyperlipidemia

Yoo WS, Koh WS, Cho BY, Choi SK

A new hypolipidemic drug, pravastatin, hydroxymethylglutaryl coenzyme A reductase inhibitor was administered to 33 patients with primary hyperlipidemia, 10mg daily for 8 weeks and sequential changes of lipid profile were...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Heritability and Segregation Analysis of the Level of LDL-Cholesterol

Jee SH, Yun JE, Nam CM, Suh I

BACKGROUND AND OBJECTIVES: The purpose of this study was to investigate the familial correlation and heritability of the LDL cholesterol level through a segregation analysis. SUBJECTS AND METHODS: This study...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Treatment Guideline for Dyslipidemia in Diabetes Mellitus

Kim SR

The recently published 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults published by the American Heart Association (AHA) and American College of...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The Relationship between Visceral & Subcutaneous Fat and Small Dense Low Density Lipoprotein Cholesterol Concentration in Type 2 Diabetic Patients

Shim WS, Kim SK, Kim HJ, Kang ES, Ahn CW, Lim SK, Lee HC, Cha BS

BACKGROUND: Visceral obesity is closely associated with cardiovascular disease (CVD). Small dense (sd) LDL is closely associated with CVD. The aim of this study was to evaluate the relationship between...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Pharmacological Strategies beyond Statins: Ezetimibe and PCSK9 Inhibitors

Choi JY, Na JO

Dyslipidemia, highly elevated, low-density lipoprotein (LDL) cholesterol, is a major cardiovascular risk factor. Statins have been proven to effectively reduce the risk of atherosclerotic cardiovascular disease (ASCVD) and are recommended...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The study of serum lipids in grossly obese elementary school students in Seoul

Choi SH, Kim KB, Park SG, Chung JT, Son CS, Tockgo YC

  • KMID: 1690701
  • J Korean Pediatr Soc.
  • 1993 Jan;36(1):73-80.
Our study surveded 418 obese first grade elementary school children(279 male and 139 female), in seoul, and measured levels of serum total cholesterol, HDL cholesterol, LDL cholesterol, triglyceride were measured...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Effect of Lovastatin on Serum Lipids in Primary Hypercholesterolemia

Park WH, Kim SW, Woo EJ, Kang SW, Hwang JY, Chae SC, Jun JE

10 Patients with primary hypercholesterolemia were treated for 12 weeks with lovastation(20mg t.i.d). Lovastatin reduced mean total and low density lipoprotein cholesterol by 43% and 57% respectively(p
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Evaluation of DiaSys(R) Reagents for the Autoanalyzer

Kim YK, Kim SS, Ma KR

  • KMID: 1963114
  • J Clin Pathol Qual Control.
  • 2001 Jun;23(1):233-238.
BACKGROUND: To establish the new method in the clinical laboratory, essential work is the choice and proper evaluation of the method to get reliable results and minimize analytical error. The...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Lipid Profile Changes in Infection of Plasmodium Vivax

Sin C, Lim DJ, Song TJ, Lee KC, Suh I, Yoon SY, Lim CS

  • KMID: 1599901
  • Korean J Infect Dis.
  • 2001 Feb;33(1):58-61.
BACKGROUND: Alteration in plasma lipid levels during malaria attacks was studied to evaluate the diagnstic values in vivax malaria. METHODS: The plasma levels of total cholesterol, triglycerides, HDL-cholesterol (HDL-c), and...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Serum Lipid Level and Risk Factors in Selected Korean Adults

The Korean Society of Circulation Collaborative Lipid Sutdy Group in 1990

BACKGROUND: Hyperlipidemia is an important public health concern because it is frequently associated with conronary heart diseases(CHD). Many researchers have attempted to measure the prevalence and extent of the relationship...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr